Table 1.

Clinical and demographic characteristics of 72 patients who underwent curative gastric resection or gastrectomy

Characteristic		Patients total
		n = 72
		No.	%
Gender	Male	48	66.7
	Female	24	33.3
Age [y]	Median	61.51
	Range	30.63 – 83.24
BMI n = 62	Median	25.2
	Range	16.0 – 37.1
ASA n = 71
	I	5	7.0
	II	42	59.2
	III	24	33.8
Medication
Cortisone	yes	0	0.0
	no	72	100.0
Immunsup.	yes	2	2.8
	no	70	97.2
HTN	yes	32	44.4
	no	40	55.6
Comorbidities
DM	no	65	90.3
	NIDDM	7	9.7
	IDDM	0	0.0
CHD	yes	7	9.7
	no	65	90.3
Cirrhosis	yes	0	0.0
	no	72	100.0
COPD	yes	0	0.0
	no	72	100.0
Primary tumor location
AEG II		22	30.6
AEG III		8	11.1
Corpus		24	33.3
Pylorus		17	23.6
unknown		1	1.4
ypUICC-Stage
0		8	11.1
I		25	34.7
II		16	22.2
III		23	31.9
ypT-Stage
0		9	12.5
1		13	18.1
2		19	26.4
3		25	34.7
4		6	8.3
ypN-Stage
0		44	61.1
1		20	27.8
2		5	6.9
3		3	4.2
ypM-Stage
0		70	97.2
x		2	2.8

BMI body mass index, ASA American Society of Anesthesiologists score, Immunsup immune suppressing medication, HTN blood pressure medication, DM diabetes mellitus, NIDDM non-insulin depended DM, IDDM insulin depended DM, CHD coronary heart disease, COPD chronic obstructive pulmonary disease, AEG adenocarcinoma of the esophageal gastric junction, UICC union internationale contre le cancer